Fractyl Price To Sales from 2010 to 2025
| GUTS Stock | 1.15 0.15 15.00% |
Check Fractyl Health, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Fractyl Health,'s main balance sheet or income statement drivers, such as Depreciation And Amortization of 500.5 K, Interest Expense of 1.3 M or Selling General Administrative of 14.1 M, as well as many indicators such as Price To Sales Ratio of 916, Dividend Yield of 0.0 or PTB Ratio of 3.31. Fractyl financial statements analysis is a perfect complement when working with Fractyl Health, Valuation or Volatility modules.
Fractyl | Price To Sales | Build AI portfolio with Fractyl Stock |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Fractyl Stock Analysis
When running Fractyl Health,'s price analysis, check to measure Fractyl Health,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fractyl Health, is operating at the current time. Most of Fractyl Health,'s value examination focuses on studying past and present price action to predict the probability of Fractyl Health,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fractyl Health,'s price. Additionally, you may evaluate how the addition of Fractyl Health, to your portfolios can decrease your overall portfolio volatility.